175 related articles for article (PubMed ID: 30204533)
1. Identification of G-Quadruplex-Binding Inhibitors of Myc Expression through Affinity Selection-Mass Spectrometry.
Flusberg DA; Rizvi NF; Kutilek V; Andrews C; Saradjian P; Chamberlin C; Curran P; Swalm B; Kattar S; Smith GF; Dandliker P; Nickbarg EB; O'Neil J
SLAS Discov; 2019 Feb; 24(2):142-157. PubMed ID: 30204533
[TBL] [Abstract][Full Text] [Related]
2. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression.
Felsenstein KM; Saunders LB; Simmons JK; Leon E; Calabrese DR; Zhang S; Michalowski A; Gareiss P; Mock BA; Schneekloth JS
ACS Chem Biol; 2016 Jan; 11(1):139-48. PubMed ID: 26462961
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a fluorescent, long chain-bridged bispurine that selectively targets the c-MYC G-quadruplex.
Hu MH; Lin JH; Huang Q
Bioorg Chem; 2022 May; 122():105750. PubMed ID: 35325695
[TBL] [Abstract][Full Text] [Related]
4. Phenanthroline polyazamacrocycles as G-quadruplex DNA binders.
Carvalho J; Quintela T; Gueddouda NM; Bourdoncle A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Org Biomol Chem; 2018 Apr; 16(15):2776-2786. PubMed ID: 29611599
[TBL] [Abstract][Full Text] [Related]
5. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
6. [Determination of the binding of natural products to the human c-myb oncogene promoter G-quadruplex DNA by capillary electrophoresis and electrospray ionization mass spectrometry].
Wang S; Yang Y; Fan S; Li H; David DYC
Se Pu; 2020 Sep; 38(9):1069-1077. PubMed ID: 34213273
[TBL] [Abstract][Full Text] [Related]
7. Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex.
Calabrese DR; Chen X; Leon EC; Gaikwad SM; Phyo Z; Hewitt WM; Alden S; Hilimire TA; He F; Michalowski AM; Simmons JK; Saunders LB; Zhang S; Connors D; Walters KJ; Mock BA; Schneekloth JS
Nat Commun; 2018 Oct; 9(1):4229. PubMed ID: 30315240
[TBL] [Abstract][Full Text] [Related]
8. Effects of G-Quadruplex-Binding Plant Secondary Metabolites on
Zenkov RG; Kirsanov KI; Ogloblina AM; Vlasova OA; Naberezhnov DS; Karpechenko NY; Fetisov TI; Lesovaya EA; Belitsky GA; Dolinnaya NG; Yakubovskaya MG
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012470
[TBL] [Abstract][Full Text] [Related]
9. A short peptide that preferentially binds c-MYC G-quadruplex DNA.
Minard A; Morgan D; Raguseo F; Di Porzio A; Liano D; Jamieson AG; Di Antonio M
Chem Commun (Camb); 2020 Aug; 56(63):8940-8943. PubMed ID: 32638724
[TBL] [Abstract][Full Text] [Related]
10. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
11. Custom G4 Microarrays Reveal Selective G-Quadruplex Recognition of Small Molecule BMVC: A Large-Scale Assessment of Ligand Binding Selectivity.
Wu G; Tillo D; Ray S; Chang TC; Schneekloth JS; Vinson C; Yang D
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751510
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein.
González V; Guo K; Hurley L; Sun D
J Biol Chem; 2009 Aug; 284(35):23622-35. PubMed ID: 19581307
[TBL] [Abstract][Full Text] [Related]
13. Constructing triazole-modified quinazoline derivatives as selective c-MYC G-quadruplex ligands and potent anticancer agents through click chemistry.
Cai JH; Yang DY; Zhang JJ; Tan JH; Huang ZS; Chen SB
Bioorg Chem; 2024 Mar; 144():107173. PubMed ID: 38335759
[TBL] [Abstract][Full Text] [Related]
14. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.
Hu MH; Wu TY; Huang Q; Jin G
Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090
[TBL] [Abstract][Full Text] [Related]
15. DDX5 helicase resolves G-quadruplex and is involved in
Wu G; Xing Z; Tran EJ; Yang D
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20453-20461. PubMed ID: 31548374
[TBL] [Abstract][Full Text] [Related]
16. Structural recognition of the MYC promoter G-quadruplex by a quinoline derivative: insights into molecular targeting of parallel G-quadruplexes.
Dickerhoff J; Dai J; Yang D
Nucleic Acids Res; 2021 Jun; 49(10):5905-5915. PubMed ID: 33978746
[TBL] [Abstract][Full Text] [Related]
17. Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer.
Pandya N; Kumar A
Sci Rep; 2021 Nov; 11(1):22909. PubMed ID: 34824301
[TBL] [Abstract][Full Text] [Related]
18. Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex.
Brown RV; Danford FL; Gokhale V; Hurley LH; Brooks TA
J Biol Chem; 2011 Nov; 286(47):41018-27. PubMed ID: 21956115
[TBL] [Abstract][Full Text] [Related]
19. G-quadruplex DNA structure is a positive regulator of
Esain-Garcia I; Kirchner A; Melidis L; Tavares RCA; Dhir S; Simeone A; Yu Z; Madden SK; Hermann R; Tannahill D; Balasubramanian S
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2320240121. PubMed ID: 38315865
[TBL] [Abstract][Full Text] [Related]
20. Fe
Malina J; Kostrhunova H; Scott P; Brabec V
Chemistry; 2021 Aug; 27(45):11682-11692. PubMed ID: 34048082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
